
Biomedical Sensor Market Report 2026
Global Outlook – By Sensor Type (Temperature Sensors, Pressure Sensors, Image Sensors, Biochemical Sensors, Acoustic Sensors), By Connectivity (Wired Biomedical Sensors, Wireless Biomedical Sensors), By Application (Diagnostics, Patient Monitoring, Therapeutics, Fitness And Wellness, Research And Development) – Market Size, Trends, Strategies, and Forecast to 2030
Biomedical Sensor Market Overview
• Biomedical Sensor market size has reached to $13.85 billion in 2025 • Expected to grow to $22.2 billion in 2030 at a compound annual growth rate (CAGR) of 9.8% • Growth Driver: Rising Prevalence Of Chronic Disease Driving The Market Growth Due To Increasing Demand For Continuous Patient Monitoring • Market Trend: Innovations in Over-the-Counter Glucose Biosensor Technology Expand Continuous Health Monitoring Accessibility • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Biomedical Sensor Market?
A biomedical sensor is a device that detects and measures biological, chemical, or physiological parameters, including glucose levels, heart rate, blood oxygen saturation, body temperature, and pressure, and converts them into electrical signals for analysis. It enables real-time health monitoring, accurate disease diagnosis, informed clinical decision-making, and effective patient management across hospitals, wearable devices, and home healthcare settings. The main sensor types of biomedical sensors include temperature sensors, pressure sensors, image sensors, biochemical sensors, and acoustic sensors. Temperature sensors refer to devices that detect and measure temperature changes in the human body or biological environments for healthcare and medical applications. These sensors use wired and wireless connectivity and are applied in diagnostics, patient monitoring, therapeutics, fitness and wellness, and research and development.
What Is The Biomedical Sensor Market Size and Share 2026?
The biomedical sensor market size has grown rapidly in recent years. It will grow from $13.85 billion in 2025 to $15.27 billion in 2026 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to increasing prevalence of chronic diseases, rising demand for continuous patient monitoring, growing adoption of wearable health devices, increasing need for early disease detection, rising demand for non-invasive diagnostic procedures.What Is The Biomedical Sensor Market Growth Forecast?
The biomedical sensor market size is expected to see strong growth in the next few years. It will grow to $22.2 billion in 2030 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to increasing demand for home-based health monitoring, rising adoption of remote patient monitoring, growing need for personalized healthcare measurements, expanding use of biomedical sensors in preventive healthcare, increasing demand for real-time physiological monitoring. Major trends in the forecast period include increasing adoption of non-invasive biomedical sensing devices, rising demand for continuous physiological parameter monitoring, growing use of wearable biomedical sensors for personal health tracking, increasing demand for real-time disease detection and diagnosis, rising preference for compact and portable biomedical sensing devices.
Global Biomedical Sensor Market Segmentation
1) By Sensor Type: Temperature Sensors, Pressure Sensors, Image Sensors, Biochemical Sensors, Acoustic Sensors 2) By Connectivity: Wired Biomedical Sensors, Wireless Biomedical Sensors 3) By Application: Diagnostics, Patient Monitoring, Therapeutics, Fitness And Wellness, Research And Development Subsegments: 1) By Temperature Sensors: Thermistor Temperature Sensors, Resistance Temperature Detector Temperature Sensors, Infrared Temperature Sensors, Thermocouple Temperature Sensors 2) By Pressure Sensors: Piezoresistive Pressure Sensors, Capacitive Pressure Sensors, Piezoelectric Pressure Sensors, Strain Gauge Pressure Sensors, Optical Pressure Sensors 3) By Image Sensors: Complementary Metal Oxide Semiconductor Image Sensors, Charge Coupled Device Image Sensors, Infrared Image Sensors, Ultrasound Image Sensors 4) By Biochemical Sensors: Enzymatic Biochemical Sensors, Immunochemical Biochemical Sensors, Electrochemical Biochemical Sensors, Optical Biochemical Sensors, Affinity Based Biochemical Sensors 5) By Acoustic Sensors: Ultrasound Sensors, Piezoelectric Acoustic Sensors, Microelectromechanical Systems Acoustic Sensors, Phonocardiography Heart Sound Sensors, Respiratory Sound Monitoring SensorsWhat Is The Driver Of The Biomedical Sensor Market?
The rising prevalence of chronic disease is expected to propel the growth of the biomedical sensor market going forward. Chronic diseases are long-term medical conditions, such as diabetes, cardiovascular disease, and cancer, that persist over an extended period and require ongoing medical management. The growing prevalence of chronic diseases is largely driven by aging populations, as older individuals are significantly more susceptible to developing multiple long-term conditions, placing increasing pressure on healthcare systems to provide continuous and proactive care. The growing burden of chronic conditions fuels demand for biomedical sensors that continuously track and transmit patient health data, enabling real-time monitoring and timely clinical interventions. For instance, in March 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, the number of tuberculosis cases increased from 8,320 in 2022 to 9,615 in 2023, representing a rise of 1,295 cases. Therefore, the rising prevalence of chronic disease is driving the growth of the biomedical sensor industry.Key Players In The Global Biomedical Sensor Market
Major companies operating in the biomedical sensor market are Johnson & Johnson, Roche Holding AG, Abbott Laboratories, Medtronic plc, Siemens Healthineers AG, GE HealthCare Technologies Inc., Koninklijke Philips N.V., Texas Instruments Incorporated, Analog Devices Inc., Becton Dickinson and Company, Honeywell International Inc., STMicroelectronics N.V., Terumo Corporation, ON Semiconductor Corporation, OMRON Corporation, DexCom Inc., Amphenol Corporation, OSI Systems Inc., ICU Medical Inc., Nihon Kohden Corporation, Merit Medical Systems Inc., iRhythm Technologies Inc., Senseonics Holdings Inc., Nonin Medical Inc.
This chart is for illustrative purposes; the full report includes a detailed competitor analysis and comprehensive overview of the top 10 companies in the market.

This chart maps companies by product innovation and brand strength, with bubble size indicating relative revenue, helping identify market leaders, challengers, and niche players. This is an illustrative chart; the full report provides a complete and accurate competitive analysis.
Global Biomedical Sensor Market Trends and Insights
Major companies operating in the biomedical sensor market are focusing on developing advanced solutions, such as over-the-counter glucose biosensors, to expand access to continuous health monitoring, improve user convenience, and support proactive wellness management. An over-the-counter glucose biosensor is a wearable sensing device that continuously measures glucose levels without requiring a prescription, enabling users to monitor glucose trends in real time. For instance, in August 2024, DexCom Inc., a US-based medical device company, launched Stelo, the first over-the-counter glucose biosensor available in the United States. It is designed for adults aged 18 years and older who are not using insulin. Stelo is an over-the-counter glucose biosensor that enables continuous glucose monitoring through a smartphone application, providing real-time glucose insights, personalized recommendations, meal logging, and activity tracking to support informed metabolic health management.What Are Latest Mergers And Acquisitions In The Biomedical Sensor Market?
In June 2026, Danaher Corporation, a US-based healthcare company, acquired Masimo Corporation for $9.9 billion. With this acquisition, Danaher aims to strengthen its diagnostics portfolio by expanding its patient monitoring capabilities, integrating Masimo's advanced sensor and AI-enabled monitoring technologies, and enhancing innovation and growth in acute care diagnostics. Masimo Corporation is a US-based medical technology company that develops and manufactures a wide range of biomedical sensors used for noninvasive patient monitoring.
Regional Insights
North America was the largest region in the biomedical sensor market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Biomedical Sensor Market?
The biomedical sensor market consists of sales of motion sensors, flow sensors, humidity sensors, and impedance sensors. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This chart presents market attractiveness based on a quantitative evaluation of growth, competition, strategic alignment, and risk, offering a clear view of opportunity areas for decision-making. This chart is for illustrative purposes; the full report contains the complete analysis.

This chart highlights the Total Addressable Market (TAM) by estimating the maximum revenue opportunity using an assumption-driven approach, supporting strategic planning and opportunity sizing across markets. The chart is illustrative; the full report provides a more comprehensive analysis.
What Key Data and Analysis Are Included in the Biomedical Sensor Market Report 2026?
The biomedical sensor market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the biomedical sensor industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Biomedical Sensor Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $15.27 billion |
| Revenue Forecast In 2030 | $22.2 billion |
| Growth Rate | CAGR of 9.8% from 2026 to 2030 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2030 |
| Segments Covered | Sensor Type, Connectivity, Application |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain. |
| Key Companies Profiled | Johnson & Johnson, Roche Holding AG, Abbott Laboratories, Medtronic plc, Siemens Healthineers AG, GE HealthCare Technologies Inc., Koninklijke Philips N.V., Texas Instruments Incorporated, Analog Devices Inc., Becton Dickinson and Company, Honeywell International Inc., STMicroelectronics N.V., Terumo Corporation, ON Semiconductor Corporation, OMRON Corporation, DexCom Inc., Amphenol Corporation, OSI Systems Inc., ICU Medical Inc., Nihon Kohden Corporation, Merit Medical Systems Inc., iRhythm Technologies Inc., Senseonics Holdings Inc., Nonin Medical Inc. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
